Successful treatment of plantar warts with intralesional bleomycin and electroporation: pilot prospective study

Successful treatment of plantar warts with intralesional bleomycin and electroporation: pilot prospective study

Authors

  • Paola Pasquali Dermatology Service, Pius Hospital De Valls, Tarragona, Spain
  • Azael Freites-Martinez Dermatology Service, Pius Hospital De Valls, Tarragona, Spain
  • Salvador Gonzalez Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA & Medicine Department, Alcalá University, Madrid, Spain
  • Enrico P. Spugnini Biopulse srl, Naples, Italy
  • Alfonso Baldi Biopulse srl, Naples & Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania “Luigi Vanvitelli”, Caserta, Italy

Keywords:

warts, bleomycin, electroporation

Abstract

Background: Numerous studies have been performed to evaluate the efficacy of intralesional bleomycin for the treatment of warts with inconsistent result. Nevertheless, it is well known that the cytotoxicity of bleomycin can be enhanced in vivo by 300 to 700-fold by electroporation.
Objective and Methods: In this article, we present an interventional, one-center, prospective case series, clinical trial of the effectiveness of intralesional bleomycin combined with electroporation for the treatment of plantar warts, in comparison to the use of intralesional bleomycin alone.
Results: The study’s cohort included 12 men and 10 women, with a mean age of 53.8 years. A total of 22 warts were treated. In dividing the patients in two groups (complete remission against all the others) and analyzing the different outcomes in the two arms of patients, a statistical significant difference was found (p=0.0015), proving a greater efficacy of the treatment with bleomycin combined with ECT as opposed to bleomycin alone. Electroporation was always well tolerated by the patients with no discomfort.
Conclusions: This study serves as a basis for the application of novel protocols in the treatment of different benign and locally malignant skin lesion by means of electroporation.

References

Ciconte A, Campbell J, Tabrizi S, Garland S, Marks R. Warts are not merely blemishes on the skin: a study on the morbidity associated with having viral cutaneous warts. Australas J Dermatol. 2003;44:169-173. PubMed CrossRef

Gibbs S, Harvey I, Sterling J, Stark R. Local treatments for cutaneous warts: systematic review. BMJ. 2002;325:461. PubMed CrossRef

Cardoso JC, Calonje E. Cutaneous manifestations of human papillomaviruses: a review. Acta Dermatovenereol Alp Pannonica Adriat. 2011;20:145-154. PubMed

Rivera A, Tyirng SK. Therapy of cutaneous human papillomavirus infections. Dermatol Ther. 2004;17:4411-4418. PubMed CrossRef

Buchanan J, Nieland-Fisher N. Document responses from patients regarding warts and current therapy. Arch Dermatol. 2004;140:487-488. PubMed CrossRef

Spugnini EP, Azzarito T, Fais S, Fanciulli M, Baldi A. Electrochemotherapy as First Line Cancer Treatment: Experiences from Veterinary Medicine in Developing Novel Protocols. Curr Cancer Drug Targets. 2016;16:43-52. PubMed

Spugnini EP, Baldi A. Electrochemotherapy in veterinary oncology: from rescue to first line therapy. Methods Mol Biol. 2014;1121:247-256. PubMed CrossRef

Spugnini EP, Melillo A, Quagliuolo L, et al. Definition of novel electrochemotherapy parameters and validation of their in vitro and in vivo effectiveness. J Cell Physiol. 2014;229:1177-1181. PubMed CrossRef

Campana LG, Testori A, Curatolo P, et al. Treatment efficacy with electrochemotherapy: A multi-institutional prospective observational study on 376 patients with superficial tumors. Eur J Surg Oncol. 2016; 42:1914-1923. PubMed CrossRef

Spugnini EP, Fais S, Azzarito T, Baldi A. Novel Instruments for the implementation of electrochemotherapy protocols: From bench side to veterinary clinic. J Cell Physiol. 2017;232:490-495. PubMed CrossRef

Kruter L, Saggar V, Akhavan A, et al. Intralesional bleomycin for warts: patient satisfaction and treatment outcomes. J Cutan Med Surg. 2015;19:470-476. PubMed CrossRef

Kollipara R, Ekhlassi E, Downing C, Guidry J, Lee M, Tyring SK. Advancements in pharmacotherapy for noncancerous manifestations of HPV. J Clin Med. 2015;4:832-846. PubMed CrossRef

Lee JH, Burm JS, Yang WY, Kang SY, Byun SW. Treatment of verruca vulgaris in both external auditory canals using bleomycin injections. Clin Exp Otorhinolaryngol. 2015;8:295-297. PubMed CrossRef

Dhar SB, Rashid MM, Islam A, Bhuiyan M. Intralesional bleomycin in the treatment of cutaneous warts: a randomized clinical trial comparing it with cryotherapy. Indian J Dermatol Venereol Leprol. 2009;75:262-267. PubMed CrossRef

Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2012;9:CD001781. PubMed CrossRef

Downloads

Published

2017-08-02

Issue

Section

Research

How to Cite

1.
Pasquali P, Freites-Martinez A, Gonzalez S, Spugnini EP, Baldi A. Successful treatment of plantar warts with intralesional bleomycin and electroporation: pilot prospective study. Dermatol Pract Concept. 2017;7(3). doi:10.5826/dpc.0703a04

Share